Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Clinical trial NCT04204252 · TERMINATED

Trial details

NCT number: NCT04204252
Sponsor: Kamada, Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2019-11-25
Primary completion: 2026-02-19
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.